Locations:
Search IconSearch
March 23, 2017/Cancer/News & Insight

New Cancer Center Houses Ohio’s Most Advanced Gamma Knife Technology

Icon one of many upgrades in new building

suh-icon_650x450

The new Taussig Cancer Center building, which opened March 6, 2017, houses Ohio’s first Leksell Gamma Knife Icon™ radiosurgery technology. Icon offers the most precise brain radiosurgery capabilities of any currently available technology.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The addition of this new technology further enhances patient care, research and education at Cleveland Clinic Cancer Center. Since 1997, the center has performed over 6000 cases using Gamma Knife for brain tumor treatment. Cleveland Clinic is also one of the few centers to offer a week-long Gamma Knife training course, which has trained hundreds of physicians and medical physicists. In addition, the center is active in scientific and clinical research, has ongoing clinical trials for patients with brain metastases and holds an annual international symposium on radiosurgery.

Upgraded features benefit patient care

Icon’s front-mounted, cone-beam CT scanner allows the physician to verify the patient’s head position prior to treatment. This verification enables physicians to treat tumors in locations close to critical structures such as the optic apparatus and brain stem, and to replace rigid frames that screw into a patient’s skull with a mask as a stereotactic reference.

The mask “offers a better patient experience for some patients and allows us to divide treatments over multiple sessions, which is useful for some complex cases,” says John Suh, MD, Chair of the Department of Radiation Oncology at Cleveland Clinic’s Taussig Cancer Center and Associate Director of the Gamma Knife Center. The presence of high-definition motion management, which uses an infrared camera, monitors any patient motion during treatment.

Icon one of many upgrades in new building

The new 377,000-square-foot, $276 million Cancer Center building is designed, top to bottom, to “optimize multidisciplinary care and patient experience and minimize wait times,” says Dr. Suh. The light-filled building extends its brightness to the lower level of the radiation treatment center with an enormous standing skylight that protrudes into the parking drop off area. “The presence of natural light into the radiation oncology department is very important. It helps make the space more open and inviting, which helps comfort patients and their families,” says Dr. Suh.

Advertisement

All radiation treatments will occur in the new Cancer Center. Six state-of-the-art linear accelerators with image guidance, two large bore CT simulators, a hyperthermia suite, a high-dose rate brachytherapy suite and MRI for simulation will join Icon in the array of radiation treatments available for Cleveland Clinic patients. In addition, the lower level will feature a large physician conference room with two 100-inch monitors.

“It’s a very exciting time in oncology, in particular radiation oncology,” says Dr. Suh. “We plan to create the future of cancer care in the new Taussig Cancer Center by providing timely, compassionate, innovative and comprehensive cancer care.”

Advertisement

Related Articles

scan showing cholangiocarcinoma
June 5, 2025/Cancer/News & Insight
Exploring Novel Therapeutic Avenues in Advanced Cholangiocarcinoma: Lessons from the EA2187 Trial

Collaborative research effort underscores the urgent need for effective second-line therapies in this rare, aggressive cancer

Anticoagulant sign
June 4, 2025/Cancer/News & Insight
Direct-Acting Oral Anticoagulants Safe for Patients with Brain Metastasis

Largest study to date comparing direct-acting oral anticoagulants to low-molecular-weight heparin

Squamous cell carcinoma
June 2, 2025/Cancer/News & Insight
Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell Carcinoma

Pembrolizumab does not improve outcomes, but immunotherapy may still offer benefit

Photonic sensor
May 22, 2025/Cancer/News & Insight
Novel Partnership Aims to Advance ctDNA Testing in Non-Small Cell Lung Cancer

Cleveland Clinic, the University of Minnesota and University of Cambridge receive $1M grant to develop point-of-care biosensor for early detection and treatment personalization

gastroesophageal cancer illustration
May 20, 2025/Cancer/News & Insight
Roughly One-Third of Patients with Metastatic Gastroesophageal Cancer May be Eligible for New Targeted Therapy

Long-acting antiemetics and high-dose steroids key to minimizing acute nausea

Neoadjuvant immunotherapy
May 16, 2025/Cancer/News & Insight
Changing Course in Treating Advanced Melanoma

Neoadjuvant immunotherapy improves outcomes

Oncologist consulting with couple
April 29, 2025/Cancer/News & Insight
Are Your Patients With Cancer Experiencing Sexual Dysfunction? Just Ask!

Sexual disorders affect patients across all cancer types

Ad